David Clark, MD
Allena Pharmaceuticals Inc
2
0
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
David Goldfarb, MD
NYU Langone Health
Shared therapeutic areas:
Dawn Milliner, MD
Mayo Clinic
Shared therapeutic areas:
Vidar Edvardsson, MD
APRT Registry, Landspitali University Hospital, Iceland
Shared therapeutic areas:
Sandrine Lemoine, MD
Hospices Civils de Lyon
Shared therapeutic areas:
Verity Rawson, MB.CHB
Dicerna, A Novo Nordisk Company
Shared therapeutic areas:
Dawn Milliner
Mayo Clinic
Shared therapeutic areas:
John C Lieske, M.D.
Mayo Clinic Department of Nephrology and Hypertension
Shared therapeutic areas:
Sonja Froschauer
Cystinosis Foundation (Cystinose Stiftung)
Shared therapeutic areas:
Dawn S. Milliner, M.D.
Primary Hyperoxaluria Registry - Mayo Clinic, Rochester, MN
Shared therapeutic areas:
John C Lieske, M.D.
Mayo Clinic
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria
Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia
All 2 trials loaded